Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

After years of counseling families through loss, I am still moved by their strength. I carry with me Eleanor’s prayer, ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Trump's order to block state AI laws could help the tech industry but hurt health systems looking to adopt AI safely, and ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...